Roivant Sciences Ltd.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Jun 2020 | $-111.2M | $-111.5M | $306.0K | $14.3M |
| Sep 2020 | $-98.0M | $-99.3M | $1.3M | $13.9M |
| Dec 2020 | $-236.9M | $-237.0M | $107.0K | $17.3M |
| Mar 2021 | $-106.1M | $-110.2M | $4.1M | $39.4M |
| Jun 2021 | $-141.2M | $-143.5M | $2.3M | $19.3M |
| Sep 2021 | $-120.6M | $-123.4M | $2.8M | $397.3M |
| Dec 2021 | $-268.5M | $-274.6M | $6.1M | $71.2M |
| Mar 2022 | $-147.5M | $-153.7M | $6.3M | $77.2M |
| Jun 2022 | $-252.1M | $-259.5M | $7.5M | $72.8M |
| Sep 2022 | $-189.6M | $-192.7M | $3.1M | $62.0M |
| Dec 2022 | $-222.6M | $-223.1M | $508.0K | $57.7M |
| Mar 2023 | $-179.1M | $-180.7M | $1.6M | $25.3M |
| Jun 2023 | $-249.9M | $-250.3M | $403.0K | $49.3M |
| Sep 2023 | $-196.4M | $-196.7M | $275.0K | $49.3M |
| Dec 2023 | $-210.5M | $-210.8M | $355.0K | $54.3M |
| Mar 2024 | $-108.5M | $-108.8M | $349.0K | $46.7M |
| Jun 2024 | $-192.8M | $-193.8M | $965.0K | $50.2M |
| Sep 2024 | $-266.8M | $-267.8M | $996.0K | $71.7M |
| Dec 2024 | $-207.3M | $-209.1M | $1.8M | $83.7M |
| Mar 2025 | $-172.6M | $-173.4M | $811.0K | $83.5M |
| Jun 2025 | $-204.4M | $-208.4M | $4.0M | $82.2M |
| Sep 2025 | $-185.7M | $-193.5M | $7.8M | $81.8M |
| Dec 2025 | $-196.5M | $-191.5M | $-4.9M | $105.0M |
| Mar 2026 | $-163.8M | $-165.1M | $1.3M | $77.2M |
| Jun 2026 | $-270.5M | $-270.9M | $419.0K | $83.3M |